Nalaganje...
Quality assessment of HER2 testing by monitoring of positivity rates
Interlaboratory variation in human epidermal growth factor receptor 2 (HER2) testing provides a challenge for targeted therapy in breast and gastric cancer. Assessment of positivity rates among laboratories could help monitor their performance and define reference values for positivity rates to be e...
Shranjeno v:
Main Authors: | , , |
---|---|
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
Springer-Verlag
2011
|
Teme: | |
Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3162627/ https://ncbi.nlm.nih.gov/pubmed/21809092 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00428-011-1132-8 |
Oznake: |
Označite
Brez oznak, prvi označite!
|